tiprankstipranks
Trending News
More News >
Primo Nutraceuticals (BUGVF)
OTHER OTC:BUGVF
US Market
Advertisement

Primo Nutraceuticals (BUGVF) Income Statement

Compare
8 Followers

Primo Nutraceuticals Income Statement

Last quarter (Q3 2020), Primo Nutraceuticals's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Primo Nutraceuticals's net income was C$-390.38K. See Primo Nutraceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 19
Total Revenue
C$ 0.00
Gross Profit
C$ 0.00
Operating Expenses
C$ 1.19M
Depreciation and Amortization
C$ 171.86K
EBITDA
C$ -1.19M
Operating Income
C$ -1.19M
Other Income/Expenses
C$ -2.68M
Pretax Income
C$ -3.87M
Net Income
C$ -3.87M
Per Share Metrics
Basic EPS
C$ -0.88
Diluted EPS
C$ -0.88
Weighted Average Shares Outstanding
4.38M
Weighted Average Shares Outstanding (Diluted)
4.38M
Currency in CAD

Primo Nutraceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis